A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 39
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : HBs
Long Form : hemangioblastomas
No. Year Title Co-occurring Abbreviation
2019 A Novel RNF139 Mutation in Hemangioblastomas: Case Report. ACMG, NGS, VHL
2019 Accelerated growth of hemangioblastoma in pregnancy: the role of proangiogenic factors and upregulation of hypoxia-inducible factor (HIF) in a non-oxygen-dependent pathway. HIF, PlGF, VEGF, VEGFR1, VHL
2018 A Comprehensive Procedure to Evaluate the In Vitro Performance of the Putative Hemangioblastoma Neovascularization Using the Spheroid Sprouting Assay. CNS, VHL
2018 Pilot study of dovitinib in patients with von Hippel-Lindau disease. AE, ccRCC, FGF, FGFR3, SD, TKI, VHL
2018 Repurposing propranolol as an antitumor agent in von Hippel-Lindau disease. IHs, RCCs, VHL, VHL-HBs
2018 Role of Endothelial-to-Mesenchymal Transition in the Pathogenesis of Central Nervous System Hemangioblastomas. CD, ECs, EndMT
2018 Staged multi-modality treatment approaches for giant cerebellopontine angle hemangioblastomas. CPA
2018 Tumors in von Hippel-Lindau Syndrome: From Head to Toe-Comprehensive State-of-the-Art Review. CNS, VHL
2017 Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan. VHL
10  2017 Differences in genetic and epigenetic alterations between von Hippel-Lindau disease-related and sporadic hemangioblastomas of the central nervous system. LOH, MLPA, SNP, VHL
11  2017 Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization. VEGF
12  2017 Expression of angiopoietins in central nervous system hemangioblastomas is associated with cyst formation. Ang-1, Ang-2, CNS, IOD
13  2017 Neuroprotective effects respond to cerebral ischemia without susceptibility to HB-tumorigenesis in VHL heterozygous knockout mice. CNS, HIF, VHL
14  2017 Whole exome sequencing identified genetic variations in Chinese hemangioblastoma patients. VHL
15  2015 ERG is a novel and reliable marker for endothelial cells in central nervous system tumors. alpha-SMA, CNS, ERG, GBMs
16  2015 Neurosurgical Management of Brainstem Hemangioblastomas: A Single-Institution Experience with 116 Patients. ---
17  2014 De novo VHL germline mutation detected in a patient with mild clinical phenotype of von Hippel-Lindau disease. VHL
18  2014 Histomorphological spectrum and immunohistochemical characterization of hemangioblastomas: an entity of unclear histogenesis. GFAP, VHL
19  2013 Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system. VHL
20  2013 Pituitary stalk hemangioblastoma in a von hippel-lindau patient : clinical course follow-up over a 20-year period. ---
21  2012 Preoperative endovascular embolization for hemangioblastoma in the posterior fossa. GDC PVA, NBCA
22  2011 Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report. CNS, CSF
23  2011 Identification of tumorigenic cells and implication of their aberrant differentiation in human hemangioblastomas. SSEA1, TICs
24  2011 N-butyl 2-cyanoacrylate (n-BCA) embolization of a cerebellar hemangioblastoma. n-BCA
25  2011 Pilot trial of sunitinib therapy in patients with von Hippel-Lindau disease. LSC, pFRS2, RCCs, VHL
26  2010 Non-von Hippel-Lindau Hemangioblastoma in the Hippocampus: Characterization with Time-Resolved MRA Using TRICKS Sequence at 3T. A Case Report. VHL
27  2010 Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma. RCC, VHL
28  2005 Coexpression of erythropoietin and its receptor in endolymphatic sac tumors. ELST, EPO, RCCs, VHL
29  2005 Hemangioblastomas of the lower spinal region: report of four cases with preoperative embolization and review of the literature. ASA
30  2005 Molecular analysis as a tool in the differential diagnosis of VHL disease-related tumors. RCCs, VHL
31  2004 Loss of heterozygosity reveals non-VHL allelic loss in hemangioblastomas at 22q13. CNS, HIFs, LOH, VHL
32  2004 [Cerebellar hemangioblastomas--a study of the immunoprofile of neoplastic stromal component]. FVIIIRAg, FXIIIa, GFAP, NF, NSE, VHL
33  2003 Haemangioblastoma of the posterior cranial fossa: clinico-neuropathological study. MRI, VHL
34  2003 The natural history of cerebellar hemangioblastomas in von Hippel-Lindau disease. VHL
35  2002 Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity. TSG, VHL
36  2001 Characteristic chromosomal aberrations in sporadic cerebellar hemangioblastomas revealed by comparative genomic hybridization. PHEO, RCC, sp, VHL
37  2001 Interferon alpha-2a therapy in 18 hemangioblastomas. CNS, VHL
38  2000 Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. GBMs, HIF-1
39  2000 Hemangioblastomas of the retina: impact of von Hippel-Lindau disease. VHL